INS and obesity disorder: These results from in vitro analyses complement knowledge of the impact of in vivo administration of 4-cresol on insulin sensitivity, improved glucose tolerance, stimulated insulin secretion, β-cell mass and β-cell proliferation, and reduced obesity and fatty liver that we demonstrated in preclinical models of type 2 diabetes [14].